CTx-1000

N/A

Report date: 2026/02/12 20:00:14

Base Information

Drug NameCTx-1000
Drug Alias NameCTx1000CTx-1000
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelosia Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCelosia Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A